The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intratumoural (IT) evolutionary landscape of high-risk prostate cancer and outcome: The PROGENY (PROstate cancer GENomic heterogeneitY) study of genomic and immune parameters.
 
Anuradha Jayaram
No Relationships to Disclose
 
Gerald Goh
No Relationships to Disclose
 
Bihani Yoshana Kularatne
Employment - Pfizer
 
Jasmin Waterhouse
No Relationships to Disclose
 
Yaalini Shanmugabavan
No Relationships to Disclose
 
Andrew Rowan
No Relationships to Disclose
 
Yien Ning Sophia Wong
No Relationships to Disclose
 
Alex Freeman
No Relationships to Disclose
 
Ayse Akarca
No Relationships to Disclose
 
Javier Herrero
No Relationships to Disclose
 
Rachel Rosenthal
No Relationships to Disclose
 
Nicholas McGranahan
No Relationships to Disclose
 
Michelle Hung
No Relationships to Disclose
 
Mark Emberton
Stock and Other Ownership Interests - Nuada Medical Ltd
Honoraria - Exact Imaging; Minomic; Profound Medical; Proteomix; SonaCare Medical; Steba Biotech
Consulting or Advisory Role - Exact Imaging; Profound Medical; Proteomix; SonaCare Medical; Steba Biotech
Speakers' Bureau - SonaCare Medical; Steba Biotech
Research Funding - SonaCare Medical; Steba Biotech
Travel, Accommodations, Expenses - Steba Biotech
 
Gerhardt Attard
Honoraria - Astellas Pharma; Janssen; Janssen (I)
Consulting or Advisory Role - Abbott Laboratories; Astellas Pharma; AstraZeneca; Bayer; ESSA; Ferring; Janssen-Cilag; Medivation; Millennium; Novartis; Pfizer; Ventana Medical Systems; Veridex
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ferring; Ipsen; Janssen; Sanofi; Takeda; Ventana Medical Systems
Research Funding - Arno Therapeutics (Inst); Innocrin Pharma (Inst); Janssen (Inst)
Patents, Royalties, Other Intellectual Property - I am on The ICR rewards to inventors list of abiraterone acetate.
Travel, Accommodations, Expenses - Abbott Laboratories; Astellas Pharma; Astellas Pharma (I); Bayer; ESSA; Ferring; Janssen; Janssen (I); Medivation; Pfizer; Ventana Medical Systems
Other Relationship - Institute of Cancer Research
 
Sergio A. Quezada
No Relationships to Disclose
 
Teresa Marafioti
No Relationships to Disclose
 
Hashim Uddin Ahmed
Research Funding - SonaCare Medical; Sophiris Bio
 
Charles Swanton
Stock and Other Ownership Interests - Achilles Therapeutics; Apogen Biotechnologies; Epic Sciences; GRAIL
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Illumina; Lilly; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Roche; SERVIER
Consulting or Advisory Role - Genentech/Roche; Sarah Cannon Research Institute
Research Funding - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche
Patents, Royalties, Other Intellectual Property - Founder of Achilles Therapeutics: a biotechnology company funded by Syncona/Wellcome Trust to target clonal Neoantigens through vaccine and cell therapy approaches; Patent WO2016174085 A1: Method for treating cancer based on identification of clonal neo-antigens; Patent WO2017042394 A1 :Methods for identifying a subject with cancer who is suitable for treatment with an immune checkpoint intervention
 
Mark David Linch
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen Oncology
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; MSD